The VP – Sales of Blonder Tongue Laboratories (NYSE: BDR) is Buying Shares

Today, the VP – Sales of Blonder Tongue Laboratories (BDRResearch Report), Jeffrey W. Smith, bought shares of BDR for $6,875.

Following this transaction Jeffrey W. Smith’s holding in the company was increased by 31.25% to a total of $55.05K. In addition to Jeffrey W. Smith, 7 other BDR executives reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

Based on Blonder Tongue Laboratories’ latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $5.63 million and GAAP net loss of $199K. In comparison, last year the company earned revenue of $5.58 million and had a GAAP net loss of $153K. Currently, Blonder Tongue Laboratories has an average volume of 36.27K.

The insider sentiment on Blonder Tongue Laboratories has been positive according to 20 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Blonder Tongue Laboratories, Inc. operates as a technology development and manufacturing company, which engages in delivering television signal encoding, transcoding, digital transport, and broadband product solutions for applications.